Empower Precision Therapies with Innovative Biopsy Testing
Over the past 12 months, liquid biopsy testing has continued to revolutionize diagnostics and personalized medicine; from the integration of AI and automation to elevate liquid biopsy capabilities, to the approval of MRD as an endpoint in Multiple Myeloma.
Cementing its position as the world’s leading forum for liquid biopsy specialists, the 9th Liquid Biopsy for Precision Oncology Summit returns to San Diego in February - with a refreshed agenda providing crucial insights spanning biomarker discovery to commercialization, and each critical step in between.
Whether you're new to the field or a seasoned expert, join over 150 of the industry’s top decision-makers from AstraZeneca, Amgen, Eli Lilly, AbbVie, BLOODPAC, Boundless Bio, and more to ensure you and your team are equipped with the insights and connections needed to effectively integrate liquid biopsies into clinical trials and drive meaningful progress in precision oncology.
To enhance your experience at the 9th Liquid Biopsy for Precision Oncology Summit we are bringing One-on-One Partnering™ to you!
Please note, One-on-One Partnering is reserved for Conference Partners, Biopharma and Academia only. Those attendees are able to set up their company profile, update calendar availability, and start requesting/accepting meetings.
Networking Opportunities
To enhance your experience at the 9th Liquid Biopsy for Precision Oncology Summit we are bringing One-on-One Partnering™ to you!
Conference Partners, Biopharma and Academic attendees are able to set up their company profile, update calendar availability, and start requesting/accepting meetings.
World-Class Speaker Faculty Includes
Rajiv Raja
Executive Director, Precision Medicine Oncology
GSK
Valerie Mbella
Global Director
Johnson & Johnson Innovative Medicine
Anneleen Daemen
Executive Director, Translational Medicine
ORIC Pharmaceuticals
Cynthia Sandoval
Senior Director, Clinical Biomarker Development
Eli Lilly
Marielana Mata
Senior Director, Clinical Biomarkers
Vividion Therapeutics
Chris Conn
Director, Clinical
Biomarkers & Diagnostics,
Global Diagnostics
Strategy Lead
Amgen
Who Attends This Meeting?
“The Liquid Biopsy for Precision Oncology Summit is a fantastic event bringing together key stakeholders across the industry. From meeting established or new vendors and learning about the latest advances in liquid biopsy research, to reconnecting with colleagues and learning how they have overcome challenges, this meeting has always delivered.”
Peter Teriete, Senior Director & Head of Lead Discovery, IDEAYA Biosciences
2025 Partners Include
Other Events in the Series
